Evidence map›Paper›PMID 27055047›Full record

ReviewCurrent opinion in hematology2016

Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31).

Panida Lertkiatmongkol, Danying Liao, Heng Mei, Yu Hu, Peter J Newman

Abstract readReview
In one paragraph

Review in Current opinion in hematology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 343 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
343citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

343 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Primary intraosseous cavernous hemangioma of the zygomatic bone.American journal of ophthalmology case reports · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. TRPV4/IP3R-1-mediated endothelial pyroptosis drives pulmonary microvascular endothelial permeability in endotoxin-induced acute lung injury.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

283 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Panida LertkiatmongkolaBlood Research Institute, BloodCenter of WisconsinbDepartment of Hematology, Union Hospital, Huazhong University of Science and TechnologycDepartments of PharmacologydCell Biology, Neurobiology and AnatomyeThe Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA*Panida Lertkiatmongkol and Danying Lio are equal co-first authors and contributed equally to the writing of this article.
Danying Liao
Heng Mei
Yu Hu
Peter J Newman

Funding

MOLECULAR BIOLOGY &FUNCTION OF PLATELET MEMBRANE GP130R01HL040926 · NHLBI · VERSITI WISCONSIN, INC. · PI NEWMAN, PETER J · 1988 to 2017
$7.4M
NHLBI NIH HHS HL40926NHLBI NIH HHS R01 HL040926
6 · The paper itself

Abstract

purpose of reviewThe purpose of this article is to describe the function of the vascular cell adhesion and signaling molecule, platelet/endothelial cell adhesion molecule-1 (PECAM-1), in endothelial cells, with special emphasis on its role in maintaining and restoring the vascular permeability barrier following disruption of the endothelial cell junction. RECENT

findingsIn addition to its role as an inhibitory receptor in circulating platelets and leukocytes, PECAM-1 is highly expressed at endothelial cell-cell junctions, where it functions as an adhesive stress-response protein to both maintain endothelial cell junctional integrity and speed restoration of the vascular permeability barrier following inflammatory or thrombotic challenge. SUMMARY: Owing to the unique ability of antibodies that bind the membrane proximal region of the extracellular domain to trigger conformational changes leading to affinity modulation and homophilic adhesion strengthening, PECAM-1 might be an attractive target for treating vascular permeability disorders.

Indexed as

Endothelial CellsHumansPlatelet Endothelial Cell Adhesion Molecule-1Platelet Endothelial Cell Adhesion Molecule-1

Identifiers

PMID27055047
PMCPMC4986701

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.